Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
grade A 52.08 -0.29% -0.15
NVO closed up 1.52 percent on Tuesday, March 19, 2019, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NVO trend table...

Date Alert Name Type % Chg
Mar 19 New 52 Week Closing High Bullish -0.29%
Mar 19 Pocket Pivot Bullish Swing Setup -0.29%
Mar 19 New 52 Week High Strength -0.29%
Mar 19 Upper Bollinger Band Walk Strength -0.29%
Mar 19 BB Squeeze Ended Range Expansion -0.29%
Mar 19 Above Upper BB Strength -0.29%
Mar 19 Gapped Up Strength -0.29%
Mar 19 Overbought Stochastic Strength -0.29%
Mar 19 Up 3 Days in a Row Strength -0.29%
Mar 19 Up 4 Days in a Row Strength -0.29%

Older signals for NVO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Obesity Hormones Insulin Peptide Hormones Biopharmaceuticals Diabetes Care Glucagon Like Peptide 1 Anti Diabetic Drugs Hormone Therapy
Is NVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.33
52 Week Low 41.23
Average Volume 1,342,341
200-Day Moving Average 47.0941
50-Day Moving Average 48.825
20-Day Moving Average 49.862
10-Day Moving Average 50.274
Average True Range 0.6142
ADX 24.94
+DI 44.1009
-DI 13.8012
Chandelier Exit (Long, 3 ATRs ) 50.4874
Chandelier Exit (Short, 3 ATRs ) 50.4426
Upper Bollinger Band 51.4935
Lower Bollinger Band 48.2305
Percent B (%b) 1.23
BandWidth 6.544062
MACD Line 0.7038
MACD Signal Line 0.5106
MACD Histogram 0.1932
Fundamentals Value
Market Cap 129.54 Billion
Num Shares 2.48 Billion
EPS 2.49
Price-to-Earnings (P/E) Ratio 20.98
Price-to-Sales 6.57
Price-to-Book 15.49
PEG Ratio 2.42
Dividend 0.95
Dividend Yield 1.82%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.95
Resistance 3 (R3) 52.90 52.62 52.83
Resistance 2 (R2) 52.62 52.43 52.64 52.79
Resistance 1 (R1) 52.42 52.32 52.52 52.47 52.75
Pivot Point 52.14 52.14 52.19 52.16 52.14
Support 1 (S1) 51.94 51.95 52.04 51.99 51.71
Support 2 (S2) 51.66 51.84 51.68 51.67
Support 3 (S3) 51.46 51.66 51.63
Support 4 (S4) 51.51